X hits on this document

PDF document

*Denotes a generic available in at least one dosage form or strength - page 7 / 26

89 views

0 shares

0 downloads

0 comments

7 / 26

This PDL reference tool is to aid a prescribing physician with generic availability and preferred product status. A "substitution allowed" physician signature on a prescription should not require a PA to be obtained if a generic agent is available.

Dexedrine*

dextroamphetamine

Focalin* Ritalin*

dexmethylphenidate methylphenidate amphetamine- dextroamphetamine

Adderall*

methylphenidate methylphenidate

methylphenidate

Desoxyn Metadate ER* Methylin* Procentra Ritalin-SR*

Adderall XR*

amphetamine- dextroamphetamine

Concerta Daytrana

Focalin XR Vyvanse

Intuniv** Metadate CD Nuvigil Provigil Ritalin LA Strattera

none

mephobarbital

Amytal Sodium Butisol Sodium Luminal Sodium Mebaral* Nembutal Sodium Seconal Sodium

phenobarbital

Diastat

N/A

  • Brand named benzodiazepines (excluding Diastat)

are non-covered by Alabama Medicaid

alprazolam alprazolam ER chlordiazepoxide clonazepam clorazepate diazepam flurazepam lorazepam midazolam oxazepam temazepam triazolam

none

zolpidem

buspirone

droperidol

zaleplon hydroxyzine chloral hydrate meprobamate

Ambien* Ambien CR Buspar* Edluar Inapsine* Lunesta Precedex Rozerem Sonata* Vistaril*

*Denotes a generic available in at least one dosage form or strength **Will be reviewed at a future time when eligible

Effective 4/1/2010

7

Document info
Document views89
Page views90
Page last viewedSun Dec 11 06:40:41 UTC 2016
Pages26
Paragraphs745
Words4095

Comments